Feldmann M - Search Results

1

TNF inhibitors are produced spontaneously by rheumatoid and osteoarthritic synovial joint cell cultures: evidence of feedback control of TNF action.

Brennan FM, Gibbons DL, Cope AP, Katsikis P, Maini RN, Feldmann M. Brennan FM, et al. Among authors: feldmann m. Scand J Immunol. 1995 Jul;42(1):158-65. doi: 10.1111/j.1365-3083.1995.tb03639.x. Scand J Immunol. 1995. PMID: 7631138

2

How does infliximab work in rheumatoid arthritis?

Maini RN, Feldmann M. Maini RN, et al. Among authors: feldmann m. Arthritis Res. 2002;4 Suppl 2(Suppl 2):S22-8. doi: 10.1186/ar549. Epub 2002 Mar 27. Arthritis Res. 2002. PMID: 12110154 Free PMC article. Review.

3

Cytokines and anti-cytokine biologicals in autoimmunity: present and future.

Andreakos ET, Foxwell BM, Brennan FM, Maini RN, Feldmann M. Andreakos ET, et al. Among authors: feldmann m. Cytokine Growth Factor Rev. 2002 Aug-Oct;13(4-5):299-313. doi: 10.1016/s1359-6101(02)00018-7. Cytokine Growth Factor Rev. 2002. PMID: 12220545 Review.

4

Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

Feldmann M, Maini RN. Feldmann M, et al. Nat Med. 2003 Oct;9(10):1245-50. doi: 10.1038/nm939. Nat Med. 2003. PMID: 14520364 No abstract available.

5

Anti-TNFalpha therapy of rheumatoid arthritis: what can we learn about chronic disease?

Feldmann M, Brennan FM, Paleolog E, Cope A, Taylor P, Williams R, Woody J, Maini RN. Feldmann M, et al. Novartis Found Symp. 2004;256:53-69; discussion 69-73, 106-11, 266-9. Novartis Found Symp. 2004. PMID: 15027483 Review.

6

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis.

Feldmann M, Brennan FM, Williams RO, Woody JN, Maini RN. Feldmann M, et al. Best Pract Res Clin Rheumatol. 2004 Feb;18(1):59-80. doi: 10.1016/j.berh.2003.09.010. Best Pract Res Clin Rheumatol. 2004. PMID: 15123038 Review.

7

Anti-TNF therapy: where have we got to in 2005?

Feldmann M, Brennan FM, Foxwell BM, Taylor PC, Williams RO, Maini RN. Feldmann M, et al. J Autoimmun. 2005;25 Suppl:26-8. doi: 10.1016/j.jaut.2005.09.006. Epub 2005 Nov 2. J Autoimmun. 2005. PMID: 16260118 Review.

8

Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures.

Sacre SM, Lo A, Gregory B, Simmonds RE, Williams L, Feldmann M, Brennan FM, Foxwell BM. Sacre SM, et al. Among authors: feldmann m. J Immunol. 2008 Dec 1;181(11):8002-9. doi: 10.4049/jimmunol.181.11.8002. J Immunol. 2008. PMID: 19017992

9

Anti-TNF therapy, from rationale to standard of care: what lessons has it taught us?

Feldmann M, Maini RN. Feldmann M, et al. J Immunol. 2010 Jul 15;185(2):791-4. doi: 10.4049/jimmunol.1090051. J Immunol. 2010. PMID: 20601610 Free article.

10

Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood.

Page TH, Turner JJ, Brown AC, Timms EM, Inglis JJ, Brennan FM, Foxwell BM, Ray KP, Feldmann M. Page TH, et al. Among authors: feldmann m. J Immunol. 2010 Sep 15;185(6):3694-701. doi: 10.4049/jimmunol.1000906. Epub 2010 Aug 16. J Immunol. 2010. PMID: 20713883 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

787 results

Search Page

Filters